Publication: D CEO Healthcare
Baylor University Medical Center and Texas Oncology announced they are now offering CAR-T therapy to treat diffuse large B-cell lymphoma. These providers are working together and are among the first in the nation to treat patients with the only CAR-T cell therapy approved by the U.S. Food and Drug Administration to treat this form of cancer.
Read the full story at D CEO Healthcare.